
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation
Katja Maurus, Anita Hufnagel, Fabienne Geiger, et al.
Oncogene (2017) Vol. 36, Iss. 36, pp. 5110-5121
Closed Access | Times Cited: 73
Katja Maurus, Anita Hufnagel, Fabienne Geiger, et al.
Oncogene (2017) Vol. 36, Iss. 36, pp. 5110-5121
Closed Access | Times Cited: 73
Showing 1-25 of 73 citing articles:
Phenotype plasticity as enabler of melanoma progression and therapy resistance
Imanol Arozarena, Claudia Wellbrock
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 377-391
Open Access | Times Cited: 325
Imanol Arozarena, Claudia Wellbrock
Nature reviews. Cancer (2019) Vol. 19, Iss. 7, pp. 377-391
Open Access | Times Cited: 325
Thyroid hormone regulates distinct paths to maturation in pigment cell lineages
Lauren M. Saunders, Abhishek Kumar Mishra, Andrew J. Aman, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 143
Lauren M. Saunders, Abhishek Kumar Mishra, Andrew J. Aman, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 143
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas
Manfred Kunz, Henry Loeffler‐Wirth, Michael Dannemann, et al.
Oncogene (2018) Vol. 37, Iss. 47, pp. 6136-6151
Closed Access | Times Cited: 92
Manfred Kunz, Henry Loeffler‐Wirth, Michael Dannemann, et al.
Oncogene (2018) Vol. 37, Iss. 47, pp. 6136-6151
Closed Access | Times Cited: 92
FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis
Zhengxin Chen, Shuai Wang, Hailin Li, et al.
Molecular Therapy (2022) Vol. 30, Iss. 7, pp. 2568-2583
Open Access | Times Cited: 42
Zhengxin Chen, Shuai Wang, Hailin Li, et al.
Molecular Therapy (2022) Vol. 30, Iss. 7, pp. 2568-2583
Open Access | Times Cited: 42
Phenotype Switching and the Melanoma Microenvironment; Impact on Immunotherapy and Drug Resistance
Sultana Mehbuba Hossain, Michael R. Eccles
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1601-1601
Open Access | Times Cited: 39
Sultana Mehbuba Hossain, Michael R. Eccles
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1601-1601
Open Access | Times Cited: 39
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
Tamer B. Shabaneh, Aleksey Molodtsov, Shannon M. Steinberg, et al.
Cancer Research (2018) Vol. 78, Iss. 17, pp. 5038-5049
Open Access | Times Cited: 79
Tamer B. Shabaneh, Aleksey Molodtsov, Shannon M. Steinberg, et al.
Cancer Research (2018) Vol. 78, Iss. 17, pp. 5038-5049
Open Access | Times Cited: 79
Expression and function of FRA1 protein in tumors
Xiao‐Yan Jiang, Hui Xie, Yingyu Dou, et al.
Molecular Biology Reports (2019) Vol. 47, Iss. 1, pp. 737-752
Closed Access | Times Cited: 69
Xiao‐Yan Jiang, Hui Xie, Yingyu Dou, et al.
Molecular Biology Reports (2019) Vol. 47, Iss. 1, pp. 737-752
Closed Access | Times Cited: 69
UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling
Anushka Dikshit, Yingai J. Jin, Simone Degan, et al.
Cancer Research (2018) Vol. 78, Iss. 22, pp. 6462-6472
Open Access | Times Cited: 59
Anushka Dikshit, Yingai J. Jin, Simone Degan, et al.
Cancer Research (2018) Vol. 78, Iss. 22, pp. 6462-6472
Open Access | Times Cited: 59
Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy
Mai Badarni, Manu Prasad, Noa Balaban, et al.
JCI Insight (2019) Vol. 4, Iss. 8
Open Access | Times Cited: 57
Mai Badarni, Manu Prasad, Noa Balaban, et al.
JCI Insight (2019) Vol. 4, Iss. 8
Open Access | Times Cited: 57
The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door
Francesco Talotta, Laura Casalino, Pasquale Verde
Oncogene (2020) Vol. 39, Iss. 23, pp. 4491-4506
Closed Access | Times Cited: 57
Francesco Talotta, Laura Casalino, Pasquale Verde
Oncogene (2020) Vol. 39, Iss. 23, pp. 4491-4506
Closed Access | Times Cited: 57
Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1
Zengli Liu, Rongqi Sun, Xiaoming Zhang, et al.
EBioMedicine (2019) Vol. 45, pp. 181-191
Open Access | Times Cited: 54
Zengli Liu, Rongqi Sun, Xiaoming Zhang, et al.
EBioMedicine (2019) Vol. 45, pp. 181-191
Open Access | Times Cited: 54
Melanoma Plasticity: Promoter of Metastasis and Resistance to Therapy
Fan Huang, François Santinon, Raúl Ernesto Flores González, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Fan Huang, François Santinon, Raúl Ernesto Flores González, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting
Laura Casalino, Francesco Talotta, Amelia Cimmino, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1480-1480
Open Access | Times Cited: 34
Laura Casalino, Francesco Talotta, Amelia Cimmino, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1480-1480
Open Access | Times Cited: 34
AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells
Natacha Comandante-Lou, Douglas G. Baumann, Mohammad Fallahi‐Sichani
Cell Reports (2022) Vol. 40, Iss. 5, pp. 111147-111147
Open Access | Times Cited: 29
Natacha Comandante-Lou, Douglas G. Baumann, Mohammad Fallahi‐Sichani
Cell Reports (2022) Vol. 40, Iss. 5, pp. 111147-111147
Open Access | Times Cited: 29
Age-related self-DNA accumulation may accelerate arthritis in rats and in human rheumatoid arthritis
Wei Luo, Yuping Wang, Jun Lv, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Wei Luo, Yuping Wang, Jun Lv, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
Mechanical confinement governs phenotypic plasticity in melanoma
Miranda V. Hunter, Emily Montal, Yilun Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Miranda V. Hunter, Emily Montal, Yilun Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells
Fan Yang, Pei Cui, Lu Yu, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 52
Fan Yang, Pei Cui, Lu Yu, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 52
EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2
Shengnan Chen, Youhong Tang, Yixin Tan, et al.
Carcinogenesis (2019) Vol. 41, Iss. 6, pp. 723-733
Open Access | Times Cited: 49
Shengnan Chen, Youhong Tang, Yixin Tan, et al.
Carcinogenesis (2019) Vol. 41, Iss. 6, pp. 723-733
Open Access | Times Cited: 49
Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 13
Hannah M. Neuendorf, Jacinta L. Simmons, Glen M. Boyle
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 13
PTEN Lipid Phosphatase Activity Suppresses Melanoma Formation by Opposing an AKT/mTOR/FRA1 Signaling Axis
Xiaonan Xu, Ilah Bok, Neel Jasani, et al.
Cancer Research (2024) Vol. 84, Iss. 3, pp. 388-404
Open Access | Times Cited: 5
Xiaonan Xu, Ilah Bok, Neel Jasani, et al.
Cancer Research (2024) Vol. 84, Iss. 3, pp. 388-404
Open Access | Times Cited: 5
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition
Sayantanee Paul, Thijs J. Hagenbeek, Julien Tremblay, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Sayantanee Paul, Thijs J. Hagenbeek, Julien Tremblay, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Multimodal diagnostic models and subtype analysis for neoadjuvant therapy in breast cancer
Zheng Ye, Jiaqi Yuan, Deqing Hong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Zheng Ye, Jiaqi Yuan, Deqing Hong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Plasticity of differentiated cells in wound repair and tumorigenesis, part II: skin and intestine
Joseph Burclaff, Jason C. Mills
Disease Models & Mechanisms (2018) Vol. 11, Iss. 9
Open Access | Times Cited: 40
Joseph Burclaff, Jason C. Mills
Disease Models & Mechanisms (2018) Vol. 11, Iss. 9
Open Access | Times Cited: 40
FOSL1 promotes tumorigenesis in colorectal carcinoma by mediating the FBXL2/Wnt/β-catenin axis via Smurf1
Yi Liu, Meng Yue, Ze Li
Pharmacological Research (2021) Vol. 165, pp. 105405-105405
Closed Access | Times Cited: 30
Yi Liu, Meng Yue, Ze Li
Pharmacological Research (2021) Vol. 165, pp. 105405-105405
Closed Access | Times Cited: 30
How Neural Crest Transcription Factors Contribute to Melanoma Heterogeneity, Cellular Plasticity, and Treatment Resistance
Anja Wessely, Theresa Steeb, Carola Berking, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5761-5761
Open Access | Times Cited: 28
Anja Wessely, Theresa Steeb, Carola Berking, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5761-5761
Open Access | Times Cited: 28